Primary |
Pain |
34.1% |
Drug Use For Unknown Indication |
16.1% |
Product Used For Unknown Indication |
9.1% |
Back Pain |
5.3% |
Procedural Pain |
5.3% |
Cancer Pain |
3.8% |
Postoperative Analgesia |
2.9% |
Neuralgia |
2.8% |
Induction Of Anaesthesia |
2.5% |
Maintenance Of Anaesthesia |
2.1% |
Drug Abuse |
2.1% |
Anaesthesia |
2.0% |
Spinal Anaesthesia |
1.9% |
Analgesia |
1.7% |
General Anaesthesia |
1.6% |
Hypertension |
1.6% |
Abdominal Pain |
1.4% |
Analgesic Therapy |
1.4% |
Sedative Therapy |
1.2% |
Breakthrough Pain |
1.1% |
|
Vomiting |
9.6% |
Completed Suicide |
9.3% |
Death |
8.1% |
Unresponsive To Stimuli |
8.0% |
Somnolence |
7.6% |
Cardio-respiratory Arrest |
7.5% |
Drug Abuse |
6.7% |
Drug Hypersensitivity |
5.9% |
Sedation |
5.4% |
Toxicity To Various Agents |
5.0% |
Overdose |
3.6% |
Medication Error |
3.5% |
Drug Ineffective |
3.3% |
Pruritus |
3.1% |
Respiratory Depression |
2.8% |
Urticaria |
2.6% |
Mental Status Changes |
2.1% |
Drug Toxicity |
2.0% |
Pulmonary Oedema |
2.0% |
Nausea |
1.8% |
|
Secondary |
Product Used For Unknown Indication |
34.8% |
Drug Use For Unknown Indication |
19.1% |
Pain |
18.7% |
Cancer Pain |
3.1% |
Analgesic Therapy |
2.9% |
Anaesthesia |
2.5% |
Back Pain |
2.4% |
Drug Abuse |
2.2% |
Depression |
2.0% |
Hypertension |
1.6% |
Neuralgia |
1.5% |
Ill-defined Disorder |
1.3% |
Spinal Anaesthesia |
1.3% |
Procedural Pain |
1.1% |
Postoperative Analgesia |
1.0% |
Pain Management |
1.0% |
Sedation |
1.0% |
Hiv Infection |
0.9% |
Breakthrough Pain |
0.9% |
Constipation |
0.8% |
|
Toxicity To Various Agents |
13.7% |
Respiratory Arrest |
10.5% |
Vomiting |
9.7% |
Drug Abuse |
8.8% |
Completed Suicide |
8.1% |
Death |
5.8% |
Somnolence |
5.5% |
Poisoning |
4.7% |
Drug Toxicity |
4.3% |
Overdose |
4.3% |
Intentional Drug Misuse |
3.3% |
Drug Ineffective |
2.8% |
Pain |
2.8% |
Hypotension |
2.5% |
Sedation |
2.4% |
Cardio-respiratory Arrest |
2.3% |
Unresponsive To Stimuli |
2.3% |
Hyperaesthesia |
2.1% |
Venoocclusive Liver Disease |
2.1% |
Renal Failure |
2.0% |
|
Concomitant |
Product Used For Unknown Indication |
32.5% |
Drug Use For Unknown Indication |
21.0% |
Pain |
13.2% |
Prophylaxis |
4.6% |
Hypertension |
3.2% |
Multiple Myeloma |
3.0% |
Nausea |
3.0% |
Constipation |
2.5% |
Depression |
2.2% |
Anxiety |
1.7% |
Back Pain |
1.7% |
Rheumatoid Arthritis |
1.7% |
Non-small Cell Lung Cancer |
1.6% |
Crohn's Disease |
1.6% |
Diabetes Mellitus |
1.1% |
Cancer Pain |
1.1% |
Insomnia |
1.1% |
Osteoporosis |
1.1% |
Breast Cancer |
1.0% |
Abdominal Pain |
1.0% |
|
Vomiting |
16.9% |
Weight Decreased |
10.3% |
Death |
7.0% |
Pain |
6.7% |
Pulmonary Embolism |
5.5% |
Sepsis |
5.4% |
Weight Increased |
4.8% |
Pneumonia |
4.6% |
Thrombocytopenia |
4.4% |
White Blood Cell Count Decreased |
4.2% |
Pyrexia |
3.7% |
Renal Failure Acute |
3.5% |
Somnolence |
3.4% |
Nausea |
3.3% |
Respiratory Failure |
3.3% |
Renal Failure |
3.2% |
Urinary Tract Infection |
3.2% |
Tremor |
2.3% |
White Blood Cell Count Increased |
2.2% |
Unresponsive To Stimuli |
2.2% |
|
Interacting |
Product Used For Unknown Indication |
24.4% |
Drug Use For Unknown Indication |
18.8% |
Pain |
13.9% |
Anaesthesia |
7.2% |
Restlessness |
5.8% |
Femur Fracture |
3.3% |
Analgesic Effect |
3.0% |
Chemotherapy |
2.8% |
Hypertension |
2.8% |
General Anaesthesia |
2.2% |
Induction Of Anaesthesia |
2.2% |
Ankle Fracture |
1.7% |
Dyspnoea |
1.7% |
Hallucination |
1.7% |
Hepatitis C |
1.7% |
Restless Legs Syndrome |
1.7% |
Ex-smoker |
1.4% |
Malignant Hydatidiform Mole |
1.4% |
Neuralgia |
1.4% |
Abdominal Pain |
1.1% |
|
Drug Interaction |
19.5% |
Sedation |
8.0% |
Respiratory Depression |
6.9% |
Respiratory Failure |
6.9% |
Therapeutic Agent Toxicity |
6.9% |
Toxicity To Various Agents |
6.9% |
Somnolence |
5.7% |
Smoker |
4.6% |
Unresponsive To Stimuli |
4.6% |
Vomiting |
4.6% |
Respiratory Arrest |
3.4% |
Weight Decreased |
3.4% |
Confusional State |
2.3% |
Dehydration |
2.3% |
Drug Level Decreased |
2.3% |
Fall |
2.3% |
General Physical Health Deterioration |
2.3% |
Infectious Peritonitis |
2.3% |
Myoclonus |
2.3% |
Overdose |
2.3% |
|